No spam - just the good stuff
Subscribe to our newsletter
First Name
(Required)
Email Address
(Required)
Hidden
Contact Source
News
Investor Portal
Lifestyle
Videos
Search for:
Search
More
Contact
Features
News
Home
Biotech
Investment
Diagnostics
Agetech
Supplements
Innovation
AI/Digital
Economy
ChromaDex
NIH study shows elevating NAD+ with NR supplementation effectively reduces inflammation
Supplements
ChromaDex and Zesty Paws team up on cellular health for dogs
Innovation
Supplements
Longevity investment bulletin: XtalPi, Levolta, MetrioPharm and more
Investment
Investment
A strong patent portfolio delivers a competitive edge in the longevity space
Investment
Investment
Supplements
Videos
Longevity investment bulletin: ChromaDex, Nightingale Health, Capsida and more
Investment
Investment
Longevity investment bulletin: Five Alarm Bio, Capsida, MyMD and more
Investment
Investment
ChromaDex and Nestlé announce new Niagen commercial supply agreement and $5m investment
Investment
Supplements
ChromaDex shares promising findings from nicotinamide riboside clinical trial
Biotech
Investment
Supplements
New immune supplement launches with NAD+ boost for optimal maintenance of aging cells
Supplements